Alkem Laboratories (NSE:ALKEM) EBIT per Share : ₹164.62 (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories EBIT per Share?

Alkem Laboratories's EBIT per Share for the three months ended in Dec. 2023 was ₹56.90. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹164.62.

During the past 12 months, the average EBIT per Share Growth Rate of Alkem Laboratories was 49.20% per year. During the past 3 years, the average EBIT per Share Growth Rate was 1.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was 12.60% per year. During the past 10 years, the average EBIT per Share Growth Rate was 16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Alkem Laboratories's EBIT per Share or its related term are showing as below:

NSE:ALKEM' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -0.4 Med: 21.7 Max: 33.6
Current: 1.6

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Alkem Laboratories was 33.60% per year. The lowest was -0.40% per year. And the median was 21.70% per year.

NSE:ALKEM's 3-Year EBIT Growth Rate is ranked worse than
59.95% of 859 companies
in the Drug Manufacturers industry
Industry Median: 7.5 vs NSE:ALKEM: 1.60

Alkem Laboratories's EBIT for the three months ended in Dec. 2023 was ₹6,804 Mil.

Alkem Laboratories EBIT per Share Historical Data

The historical data trend for Alkem Laboratories's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkem Laboratories EBIT per Share Chart

Alkem Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT per Share

Get a 7-Day Free Trial

84.01

109.90

158.15

157.67

116.97

Alkem Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															47.33	18.98	32.00	56.74	56.90

Alkem Laboratories EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Alkem Laboratories's EBIT per Share for the fiscal year that ended in Mar. 2023 is calculated as

	EBIT per Share		(A: Mar. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	13985.2	/	119.565
=	116.97

Alkem Laboratories's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	6803.6	/	119.566
=	56.90

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹164.62

Alkem Laboratories (NSE:ALKEM) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Alkem Laboratories EBIT per Share Related Terms

Thank you for viewing the detailed overview of Alkem Laboratories's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Alkem Laboratories (NSE:ALKEM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » EBIT per Share

Traded in Other Exchanges

539523:India

Address

Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013

Website

https://www.alkemlabs.com

Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines